| Outcome Measures: |
Primary: Difference in the Percent Change in Fasting Nuclear Factor Kappa-light-chain-enhancer of Activated B Cells Activation (DNA Binding Activity) in Mononuclear Cells Before and After Dapagliflozin Use, nuclear factor kappa-light-chain-enhancer of activated B cells measurement through Transcription factor assay, 12 weeks | Secondary: Changes in Expression of Inflammatory Mediators, p47phox in mononuclear cells through real time polymerase chain reaction, 12 Weeks|Changes in Expression of Inflammatory Mediators, Suppressor Of Cytokine Signaling 3 measurement in Mononuclear cells through real time polymerase chain reaction, 12 weeks|Changes in Expression of Inflammatory Mediators, Interleukin 1 Beta measurement in mononuclear cells through real time polymerase chain reaction, 12 weeks|Changes in Expression of Inflammatory Mediators, c-Jun N-terminal kinase 1 measurement in Mononuclear cells through real time polymerase chain reaction, 12 weeks|Changes in Expression of Inflammatory Mediators, Toll-like receptor 4 measurement in mononuclear cells through real time polymerase chain reaction, 12 weeks|Changes in Expression of Inflammatory Mediators, Tumor necrosis factor alpha measurement in mononuclear through real time polymerase chain reaction, 12 weeks | Other: Change in Hypertension Mediators, Plasma concentrations measurement of Angiotensinogen through enzyme-linked immunosorbent assay, 12 weeks|Change in Hypertension Mediators, Plasma concentration measurement of Angitosensin II through enzyme-linked immunosorbent assay, 12 weeks|Change in Hypertension Mediators, Plasma concentration measurement of Renin through enzyme-linked immunosorbent assay, 12 weeks|Change in Hypertension Mediators, Plasma concentration measurement of Atrial natriuretic peptide through enzyme linked immunosorbent assay, 12 weeks|Change in Hypertension Mediators, Plasma concentration measurement of B-type natriuretic peptide through enzyme linked immunosorbent assay, 12 weeks|Change in Hypertension Mediators, Plasma concentration measurement of Cyclic guanosine monophosphate through enzyme linked immunosorbent assay, 12 weeks|Change in Hypertension Mediators, Plasma concentration measurment of Cyclic adenosine monophosphate through enzyme linked immunosorbent assay, 12 week
|
